Azapropazone

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Azapropazone
Azapropazone.svg
Azapropazone molecule
Clinical data
Trade namesRheumox
AHFS/Drugs.comInternational Drug Names
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Elimination half-life20 hours
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard100.033.543 Edit this at Wikidata
Chemical and physical data
FormulaC16H20N4O2
Molar mass300.36 g/mol g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
 ☒N☑Y (what is this?)  (verify)

Azapropazone is a nonsteroidal anti-inflammatory drug (NSAID). It is manufactured by Goldshield under the tradename Rheumox.[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]

References[edit]

  1. ^ http://home.intekom.com/pharm/cont_eth/rheumox.html
  2. ^ http://www.patient.co.uk/showdoc/30002267/
  3. ^ Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.